Shivalik Rasayan’s API facility gets 7 observations from USFDA
Drug Approval

Shivalik Rasayan’s API facility gets 7 observations from USFDA

These observations are procedural in nature and will be responded within the stipulated time

  • By IPP Bureau | April 10, 2024

The United States Food and Drug Administration (US FDA) inspected the API facility of Shivalik Rasayan Limited at Dahej- II, Industrial Estate V- Vaddala TVagra, Bharuch, Gujarat from April 01, 2024 and concluded on April 09, 2024.

The inspection closed successfully with 7 observations only. These observations are procedural in nature and will be responded within the stipulated time.

Upcoming E-conference

Other Related stories

Startup

Digitization